For most investors, the stock market is a popularity contest. For me, it's a scavenger hunt. I'm not looking for the stocks everyone already loves. By the time financial television is discussing them nonstop and social media has turned them into cults, the easy money is often gone. The crowd has arrived. The narrative has formed. The expectations are sky-high. I'm looking for something different. I'm looking for catalysts. Specifically, I'm looking for moments when reality is changing faster than Wall Street's perception of reality. That's where pharmaceutical stocks become fascinating. Not because they're easy. Not because they're predictable. And certainly not because they don't occasionally resemble a casino run by molecular biologists. They're fascinating because few sectors create larger disconnects between present value and future value. A biotech company can look worthless today and become enormously valuable tomorrow. Like...